http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2164701-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5555 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56911 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-102 |
filingDate | 1994-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be85691ccc528d15c0aa2dba191daccb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f427e2dfabacca88c0b63c3639049692 |
publicationDate | 1994-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2164701-A1 |
titleOfInvention | Pasteurella haemolytica subunit vaccine containing capsular polysaccharide and muramyl dipeptide |
abstract | Protection of ruminants against bacterial pneumonia caused by Pasteurella haemolytica has been achieved with a subunit vaccine. The vaccine contains two principle components; capsular polysaccharide of P. haemolytica and a synthetic adjuvant, muramyl dipeptide. This vaccine prevented bacterial infection of the lungs of vaccinated animals upon challenge with P. haemolytica. In contrast, animals that were not vaccinated or animals that were vaccinated with only capsular polysaccharide alone had severe lesions and high concentrations of P. haemolytica in the lungs. |
priorityDate | 1993-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.